Viridian Pharma - VRDN Net earnings per one share for the last twelve months

Public company logo of Viridian Pharma (VRDN)

Viridian Therapeutics (VRDN) relies on the development of antibodies for eye and thyroid therapies, reducing long-term risks. The EPS YoY growth rate (trailing 12 months) visualizes this trend, where the level of -18.30 is the current value. The company's developments make the treatment of ophthalmopathies safer, and the transition to subcutaneous injections is aggressively disrupting established intravenous therapy standards.

VRDN viridiantherapeutics.com: Net earnings per share for the last 12 months in the range 02/11/2024 - 11/18/2026

VRDN (Viridian Therapeutics): analytical breakdowns and indicator data

Fundamental company valuation:VRDN (Viridian Therapeutics, Inc.)
Original product of Viridian Corp

To isolate fundamental stability from market noise, it is necessary to analyze the year-over-year dynamics of net earnings per share over the last twelve months. By analyzing the EPS YoY growth rate (trailing 12 months), an investor assesses profit generation efficiency, which is critical for Viridian Therapeutics (VRDN) due to high R&D capital burn and a lack of regular commercial revenue.

Competitor analysis for Viridian Therapeutics

Net earnings per one share for the last twelve months Alcon Inc|BLCO: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Glaukos Medical (GKOS)|Earnings per share for the last twelve months apellis.com|Belite Bio (BLTE) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Ocular Pharma (OCUL)|HROW (Harrow) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) LENZ (lenz-tx.com)|Net earnings per share (EPS TTM) oculis.com OCS|EyePoint Pharmaceuticals Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Kodiak Sciences Inc. KOD|ALDX: Net earnings per share (EPS TTM)|KALA BIO, Inc. (KALA) - Net earnings per share (EPS TTM)|IRD (Opus Genetics Inc) - Net earnings per share (EPS TTM)|OKYO: Earnings per share for the trailing year|Net earnings per share for the last 12 months ADVM (adverum.com)|OTLK - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CLSD (Clearside Biomedical Inc)|Earnings per share for the trailing year NBY|Kiora Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ALIM (Alimera Sciences, Inc.)|EYEN (Eyenovia Corp) - Net earnings per share for the last 12 months|Guardion Health Science - Earnings per share for the trailing year|Earnings per share for the last twelve months Ocuphire Pharma, Inc.|Opthea Ltd. (OPT) - Net earnings per share for the last four quarters